Primary nephrotic syndrome in adults as a risk factor for pulmonary embolism: An up-to-date review of the literature

International Journal of Nephrology

Volumn 2014, Issue , 2014, Pages

  Mirrakhimov, Aibek E ^a   Ali, Alaa M ^a   Barbaryan, Aram ^a   Prueksaritanond, Suartcha ^a   Hussain, Nasir ^a,b  

^a SAINT JOSEPH HOSPITAL   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899995901     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2014/916760     Document Type: Review

References (70)

1. Cameron J. S., Hicks J., The origins and development of the concept of a 'nephrotic syndrome'. American Journal of Nephrology 2002 22 2-3 240 247 2-s2.0-0036340821 10.1159/000063768
2. Hull R. P., Goldsmith D. J. A., Nephrotic syndrome in adults. British Medical Journal 2008 336 7654 1185 1189 2-s2.0-44449110063 10.1136/bmj.39576. 709711.80
3. Glassock R. J., Attending rounds: an older patient with nephrotic syndrome. Clinical Journal of the American Society of Nephrology 2012 7 4 665 670 2-s2.0-84859526138 10.2215/CJN.12771211
4. Meyrier A., Focal and segmental glomerulosclerosis: multiple pathways are involved. Seminars in Nephrology 2011 31 4 326 332 2-s2.0-79961242353 10.1016/j.semnephrol.2011.06.003
5. Weening J. J., D'Agati V. D., Schwartz M. M., Seshan S. V., Alpers C. E., Appel G. B., Balow J. E., Bruijn J. A., Cook T., Ferrario F., Fogo A. B., Ginzler E. M., Hebert L., Hill G., Hill P., Jennette J. C., Kong N. C., Lesavre P., Lockshin M., Looi L.-M., Makino H., Moura L. A., Nagata M., The classification of glomerulonephritis in systemic lupus erythematosus revisited. Journal of the American Society of Nephrology 2004 15 3 241 250 2-s2.0-10744223000
6. Takach Lapner S., Kearon C., Diagnosis and management of pulmonary embolism. British Medical Journal 2013 346 f757 10.1136/bmj.f757
7. Pulido T., Aranda A., Zevallos M. A., Bautista E., Martínez-Guerra M. L., Santos L. E., Sandoval J., Pulmonary embolism as a cause of death in patients with heart disease: an autopsy study. Chest 2006 129 5 1282 1287 2-s2.0-33646494318 10.1378/chest.129.5.1282
8. Heit J. A., Michael O'Fallon W., Petterson T. M., Lohse C. M., Silverstein M. D., Mohr D. N., Joseph Melton L. III, Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Archives of Internal Medicine 2002 162 11 1245 1248 2-s2.0-0037054040
9. Zöller B., Li X., Sundquist J., Sundquist K., Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. The Lancet 2012 379 9812 244 249 2-s2.0-84856095858 10.1016/S0140-6736(11)61306-8
10. Mirrakhimov A. E., Hill N. S., Primary antiphospholipid syndrome and pulmonary hypertension. Current Pharmaceutical Design 2014 20 545 551 10.2174/138161282004140213125951
11. Lauw M. N., van Doormaal F. F., Middeldorp S., Buller H. R., Cancer and venous thrombosis: current comprehensions and future perspectives. Seminars in Thrombosis and Hemostasis 2013 39 507 514 10.1055/s-0033-1343891
12. Remuzzi G., Mecca G., Marchesi D., Platelet hyperaggregability and the nephrotic syndrome. Thrombosis Research 1979 16 3-4 345 354 2-s2.0-0018581515
13. Walter E., Deppermann D., Andrassy K., Koderisch J., Platelet hyperaggregability as a consequence of the nephrotic syndrome. Thrombosis Research 1981 23 6 473 479 2-s2.0-0019791777
14. Sirolli V., Ballone E., Garofalo D., Merciaro G., Settefrati N., Di Mascio R., Di Gregorio P., Bonomini M., Platelet activation markers in patients with nephrotic syndrome: a comparative study of different platelet function tests. Nephron 2002 91 3 424 430 2-s2.0-0035996178 10.1159/000064282
15. Mittal A., Aggarwal K. C., Saluja S., Aggarwal A., Sureka B., Platelet functions and coagulation changes in Indian children with nephrotic syndrome. Journal of Clinical and Diagnostic Research 2013 7 1647 1650
16. Ting H. J., Murad J. P., Espinosa E. V., Khasawneh F. T., Thromboxane A2 receptor: biology and function of a peculiar receptor that remains resistant for therapeutic targeting. Journal of Cardiovascular Pharmacology and Therapeutics 2012 17 248 259 10.1177/1074248411424145
17. Astudillo A. M., Balgoma D., Balboa M. A., Balsinde J., Dynamics of arachidonic acid mobilization by inflammatory cells. Biochimica et Biophysica Acta 2012 1821 2 249 256 2-s2.0-83455203613 10.1016/j.bbalip.2011.11.006
18. Yoshida N., Aoki N., Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome. Blood 1978 52 5 969 977 2-s2.0-0018215802
19. Jackson C. A., Greaves M., Patterson A. D., Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome. British Journal of Haematology 1982 52 1 69 77 2-s2.0-0019943364
20. Schieppati A., Dodesini P., Benigni A., The metabolism of arachidonic acid by platelets in nephrotic syndrome. Kidney International 1984 25 4 671 676 2-s2.0-0021152849
21. Mikhailidis D. P., Ganotakis E. S., Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets 1996 7 3 125 137 2-s2.0-0029789683
22. Zwaginga J. J., Koomans H. A., Sixma J. J., Rabelink T. J., Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. Journal of Clinical Investigation 1994 93 1 204 211 2-s2.0-0028057277
23. Shattil S. J., Anaya-Galindo R., Bennett J., Platelet hypersensitivity induced by cholesterol incorporation. Journal of Clinical Investigation 1975 55 3 636 643 2-s2.0-0016610186
24. Machleidt C., Mettang T., Stärz E., Weber J., Risler T., Kuhlmann U., Multifactorial genesis of enhanced platelet aggregability in patients with nephrotic syndrome. Kidney International 1989 36 6 1119 1124 2-s2.0-0024840353
25. Ozanne P., Francis R. B., Meiselman H. J., Red blood cell aggregation in nephrotic syndrome. Kidney International 1983 23 3 519 525 2-s2.0-0020569859
26. Bohler T., Linderkamp O., Leo A., Wingen A.-M., Scharer K., Increased aggregation with normal surface charge and deformability of red blood cells in children with nephrotic syndrome. Clinical Nephrology 1992 38 3 119 124 2-s2.0-0026767716
27. Patnaik M. M., Moll S., Inherited antithrombin deficiency: a review. Haemophilia 2008 14 6 1229 1239 2-s2.0-55949104988 10.1111/j.1365-2516.2008. 01830.x
28. Kauffmann R. H., Veltkamp J. J., van Tilburg N. H., van Es L. A., Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. American Journal of Medicine 1978 65 4 607 613 2-s2.0-0018086618
29. Jørgensen K. A., Stoffersen E., Antithrombin III and the nephrotic syndrome. Scandinavian Journal of Haematology 1979 22 5 442 448 2-s2.0-0018778493
30. Vaziri N. D., Paule P., Toohey J., Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Archives of Internal Medicine 1984 144 9 1802 1803 2-s2.0-0021226980 10.1001/archinte.144.9.1802
31. Chen T.-Y., Huang C.-C., Tsao C.-J., Hemostatic molecular markers in nephrotic syndrome. American Journal of Hematology 1993 44 4 276 279 2-s2.0-0027374633 10.1002/ajh.2830440411
32. Bereczky Z., Ková K. B., Muszbek L., Protein C and protein S deficiencies: similarities and differences between two brothers playing in the same game. Clinical Chemistry and Laboratory Medicine 2010 48 1 S53 S66 2-s2.0-79251610964 10.1515/CCLM.2010.369
33. Cosio F. G., Harker C., Batard M. A., Brandt J. T., Griffin J. H., Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria. The Journal of Laboratory and Clinical Medicine 1985 106 2 218 222 2-s2.0-0022111559
34. Vigano-D'Angelo S., D'Angelo A., Kaufman C. E. Jr., Sholer C., Esmon C. T., Comp P. C., Protein S deficiency occurs in the nephrotic syndrome. Annals of Internal Medicine 1987 107 1 42 47 2-s2.0-0023279753
35. Comp P. C., Doray D., Patton D., Esmon C. T., An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1986 67 2 504 508 2-s2.0-0022636454
36. Öskayin N., Mir S., Kavakli K., Hypercoagulability risk factors in children with minimal change disease and the protective role of protein-C activity. International Urology and Nephrology 2004 36 4 599 603 2-s2.0-13444259721 10.1007/s11255-004-0868-3
37. Al-Mugeiren M. M., Abdel Gader A. G. M., Al-Rasheed S. A., Al-Salloum A. A., Tissue factor pathway inhibitor in childhood nephrotic syndrome. Pediatric Nephrology 2006 21 6 771 777 2-s2.0-33646696562 10.1007/s00467-006-0061-2
38. de Sain-van der Velden M. G. M., Kaysen G. A., de Meer K., Stellaard F., Voorbij H. A. M., Reijngoud D.-J., Rabelink T. J., Koomans H. A., Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: measurements with stable isotopes. Kidney International 1998 53 1 181 188 2-s2.0-0031951669 10.1046/j.1523-1755.1998.00729.x
39. Loscalzo J., Venous thrombosis in the nephrotic syndrome. The New England Journal of Medicine 2013 368 956 958 10.1056/NEJMcibr1209459
40. Schlegel N., Thromboembolic risks and complications in nephrotic children. Seminars in Thrombosis and Hemostasis 1997 23 3 271 280 2-s2.0-0030879117
41. Meijers J. C. M., Tekelenburg W. L. H., Bouma B. N., Bertina R. M., Rosendaal F. R., High levels of coagulation factor XI as a risk factor for venous thrombosis. The New England Journal of Medicine 2000 342 10 696 701 2-s2.0-0034099043 10.1056/NEJM200003093421004
42. Thomson C., Forbes C. D., Prentice C. R. M., Kennedy A. C., Changes in blood coagulation and fibrinolysis in the nephrotic syndrome. Quarterly Journal of Medicine 1974 43 171 399 407 2-s2.0-0016201970
43. Svenningsen P., Bistrup C., Friis U. G., Bertog M., Haerteis S., Krueger B., Stubbe J., Jensen O. N., Thiesson H. C., Uhrenholt T. R., Jespersen B., Jensen B. L., Korbmacher C., SkøTt O., Plasmin in nephrotic urine activates the epithelial sodium channel. Journal of the American Society of Nephrology 2009 20 2 299 310 2-s2.0-59949102903 10.1681/ASN.2008040364
44. Soulat T., Loyau S., Baudouin V., Maisonneuve L., Hurtaud-Roux M.-F., Schlegel N., Loirat C., Anglés-Cano E., Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding: an in vitro study using plasma from children with idiopathic nephrotic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 2 575 584 2-s2.0-0033964313
45. Yoshida Y., Shiiki H., Iwano M., Uyama H., Hamano K., Nishino T., Dohi K., Shiiki H., Enhanced expression of plasminogen activator inhibitor 1 in patients with nephrotic syndrome. Nephron 2001 88 1 24 29 2-s2.0-0035004478 10.1159/000045954
46. Collet J.-P., Mishal Z., Lesty C., Mirshahi M., Peynet J., Baumelou A., Bensman A., Soria J., Soria C., Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: Influence of plasma biochemical modifications. A possible mechanism for the high thrombotic tendency? Thrombosis and Haemostasis 1999 82 5 1482 1489 2-s2.0-0032728127
47. Barbour S. J., Greenwald A., Djurdjev O., Levin A., Hladunewich M. A., Nachman P. H., Hogan S. L., Cattran D. C., Reich H. N., Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney International 2012 81 2 190 195 2-s2.0-84855189409 10.1038/ki.2011.312
48. Lionaki S., Derebail V. K., Hogan S. L., Barbour S., Lee T., Hladunewich M., Greenwald A., Hu Y., Jennette C. E., Charles Jennette J., Falk R. J., Cattran D. C., Nachman P. H., Reich H. N., Venous thromboembolism in patients with membranous nephropathy. Clinical Journal of the American Society of Nephrology 2012 7 1 43 51 2-s2.0-84857072555 10.2215/CJN.04250511
49. Cherng S.-C., Huang W.-S., Wang Y.-F., Yang S.-P., Lin Y.-F., The role of lung scintigraphy in the diagnosis of nephrotic syndrome with pulmonary embolism. Clinical Nuclear Medicine 2000 25 3 167 172 2-s2.0-0033955722 10.1097/00003072-200003000-00001
50. Kuhlmann U., Steurer J., Bollinger A., Pouliadis G., Briner J., Siegenthaler W., Incidence and clinical significance of thromboses and thrombo-embolic complications in nephrotic syndrome patients. Schweizerische Medizinische Wochenschrift 1981 111 1034 1040
51. Eddy A. A., Symons J. M., Nephrotic syndrome in childhood. The Lancet 2003 362 9384 629 639 2-s2.0-0042466540 10.1016/S0140-6736(03)14184-0
52. Wilbur J., Shian B., Diagnosis of deep venous thrombosis and pulmonary embolism. American Family Physician 2012 86 913 919
53. Wells P. S., Anderson D. R., Rodger M., Forgie M., Kearon C., Dreyer J., Kovacs G., Mitchell M., Lewandowski B., Kovacs M. J., Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. The New England Journal of Medicine 2003 349 13 1227 1235 2-s2.0-0141796729 10.1056/NEJMoa023153
54. Oudega R., Hoes A. W., Moons K. G. M., The Wells rule does not adequately rule out deep venous thrombosis in primary care patients. Annals of Internal Medicine 2005 143 2 100 107 2-s2.0-22144482023
55. van Belle A., Büller H. R., Huisman M. V., Huisman P. M., Kaasjager K., Kamphuisen P. W., Kramer M. H., Kruip M. J., Kwakkel-van Erp J. M., Leebeek F. W., Nijkeuter M., Prins M. H., Sohne M., Tick L. W., Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. Journal of the American Medical Association 2006 295 2 172 179 10.1001/jama.295.2.172
56. Kucher N., Goldhaber S. Z., Management of massive pulmonary embolism. Circulation 2005 112 2 e28 e32 2-s2.0-29244459222
57. Kayali F., Najjar R., Aswad F., Matta F., Stein P. D., Venous thromboembolism in patients hospitalized with nephrotic syndrome. American Journal of Medicine 2008 121 3 226 230 2-s2.0-39849085698 10.1016/j.amjmed.2007. 08.042
58. Suri D., Ahluwalia J., Saxena A. K., Sodhi K. S., Singh P., Mittal B. R., Das R., Rawat A., Singh S., Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. Clinical and Experimental Nephrology 2013
59. Sarasin F. P., Schifferli J. A., Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy. Kidney International 1994 45 2 578 585 2-s2.0-0028118472
60. Rostoker G., Durand-Zaleski I., Petit-Phar M., Ben Maadi A., Jazaerli N., Radier C., Rahmouni A., Mathieu D., Vasile N., Rosso J., Meignan M., Remy P., Lang P., Weil B., Prevention of thrombotic complications of the nephrotic syndrome by the low-molecular weight heparin Enoxaparin. Nephron 1995 69 1 20 28 2-s2.0-0028855813
61. Lee T., Biddle A. K., Lionaki S., Derebail V. K., Barbour S. J., Tannous S., Hladunewich M. A., Hu Y., Poulton C. J., Mahoney S. L., Charles Jennette J., Hogan S. L., Falk R. J., Cattran D. C., Reich H. N., Nachman P. H., Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. Kidney International 2013
62. Medjeral-Thomas N., Ziaj S., Condon M., Galliford J., Levy J., Cairns T., Griffith M., Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome. Clinical Journal of the American Society of Nephrology 2014 9 3 478 483 10.2215/CJN.07190713
63. Li L., Sun T., Zhang P., Tian J., Yang K., Statins for primary prevention of venous thromboembolism. Cochrane Database of Systematic Reviews 2011 12 CD008203 2-s2.0-84856285261
64. Becattini C., Agnelli G., Schenone A., Eichinger S., Bucherini E., Silingardi M., Bianchi M., Moia M., Ageno W., Vandelli M. R., Grandone E., Prandoni P., Aspirin for preventing the recurrence of venous thromboembolism. The New England Journal of Medicine 2012 366 1959 1967 10.1056/NEJMoa1114238
65. Sachdeva A., Dalton M., Amaragiri S. V., Lees T., Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database of Systematic Reviews 2010 7 CD001484 2-s2.0-77955502691
66. Osinbowale O., Ali L., Chi Y.-W., Venous thromboembolism: a clinical review. Postgraduate Medicine 2010 122 2 54 65 2-s2.0-77950348481 10.3810/pgm.2010.03.2122
67. Greenfield L. J., Cho K. J., Proctor M. C., Sobel M., Shah S., Wingo J., Late results of suprarenal Greenfield vena cava filter placement. Archives of Surgery 1992 127 8 969 973 2-s2.0-0026774598
68. Nazzal M., Chan E., Nazzal M., Abbas J., Erikson G., Sediqe S., Gohara S., Complications related to inferior vena cava filters: a single-center experience. Annals of Vascular Surgery 2010 24 4 480 486 2-s2.0-77951667769 10.1016/j.avsg.2009.07.015
69. Angel L. F., Tapson V., Galgon R. E., Restrepo M. I., Kaufman J., Systematic review of the use of retrievable inferior vena cava filters. Journal of Vascular and Interventional Radiology 2011 22 11 1522 1530 2-s2.0-80054888214 10.1016/j.jvir.2011.08.024
70. Sarosiek S., Crowther M., Sloan J. M., Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Internal Medicine 2013 173 513 517